Axolab Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-12-2024
- Paid Up Capital ₹ 4.00 M
as on 30-12-2024
- Company Age 2 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Axolab Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Abhishek Patwardhan, Ashlesha Patwardhan, and Sadhana Patwardhan serve as directors at the Company.
- CIN/LLPIN
U24100MH2022PTC385778
- Company No.
385778
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Axolab Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Patwardhan  | Director | 30-Jun-2022 | Current |
| Ashlesha Patwardhan | Director | 30-Jun-2022 | Current |
| Sadhana Patwardhan | Director | 30-Jun-2022 | Current |
Financial Performance of Axolab Pharmaceuticals.
Axolab Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Axolab Pharmaceuticals?
Unlock access to Axolab Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ketkar Maternity Hospital And Research Institute Private LimitedActive 2 years 2 monthsAbhishek Patwardhan, Ashlesha Patwardhan and 1 more are mutual person
- Jayant Patwardhan Fluent Technologies Private LimitedActive 4 years 5 months
Abhishek Patwardhan is a mutual person
- Nagpur Test Tube Baby Centre Private LimitedActive 25 years 4 months
Sadhana Patwardhan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Axolab Pharmaceuticals?
Axolab Pharmaceuticals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Axolab Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axolab Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
